Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Cyclopentolate
Drug ID BADD_D00547
Description A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.
Indications and Usage Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Marketing Status approved
ATC Code S01FA04
DrugBank ID DB00979
KEGG ID D07759
MeSH ID D003519
PubChem ID 2905
TTD Drug ID D0B1EV
NDC Product Code Not Available
UNII I76F4SHP7J
Synonyms Cyclopentolate | Cyclogyl
Chemical Information
Molecular Formula C17H25NO3
CAS Registry Number 512-15-2
SMILES CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.0010.002448%
Agitation17.02.05.012; 19.06.02.001--
Anaphylactic reaction10.01.07.001; 24.06.03.0060.004081%
Anticholinergic syndrome17.05.01.0010.002448%-
Apnoea22.02.01.0010.002448%
Arrhythmia supraventricular02.03.03.0010.001632%-
Ataxia08.01.02.004; 17.02.02.0010.001632%
Blindness06.02.10.003; 17.17.01.0030.001632%-
Bradycardia02.03.02.0020.001632%-
Cardiac arrest02.03.04.0010.001632%
Chest discomfort02.02.02.009; 08.01.08.019; 22.12.02.0020.001632%-
Chorioretinitis06.04.06.003; 11.01.06.010---
Choroiditis06.04.06.004---
Coma17.02.09.001---
Confusional state17.02.03.005; 19.13.01.0010.005713%
Conjunctivitis06.04.01.002; 11.01.06.012--
Conjunctivitis allergic06.04.01.003; 10.01.04.002---
Coordination abnormal17.02.02.004---
Cyanosis02.11.04.004; 22.02.02.007; 23.06.04.005; 24.03.01.0070.002448%
Depressed level of consciousness17.02.04.002--
Depression19.15.01.001--
Dermatitis23.03.04.002---
Disorientation17.02.05.015; 19.13.01.0020.003591%-
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.0070.006856%
Drug hypersensitivity10.01.01.0010.001632%-
Drug interaction08.06.03.0010.001632%-
Dry mouth07.06.01.002--
Dry skin23.03.03.0010.001632%
Dyspnoea02.11.05.003; 22.02.01.0040.002448%
Erythema23.03.06.0010.005713%-
The 1th Page    1 2 3    Next   Last    Total 3 Pages